Bora Pharmaceuticals Co., Ltd. (TPE:6472)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
455.00
-6.00 (-1.30%)
At close: Mar 26, 2026

Bora Pharmaceuticals Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
57,78060,52477,71264,61231,12112,446
Market Cap Growth
-37.88%-22.12%20.27%107.61%150.04%17.05%
Enterprise Value
72,96177,66792,09167,75236,58413,828
Last Close Price
455.00488.00615.75515.21254.86101.35
PE Ratio
19.5820.3020.1721.3222.3616.60
Forward PE
19.3011.8716.0721.0311.5715.18
PS Ratio
3.043.184.464.552.972.54
PB Ratio
3.313.465.215.496.053.95
P/TBV Ratio
6.326.6214.8318.9513.074.18
P/FCF Ratio
16.1616.93171.9614.9717.1411.60
P/OCF Ratio
12.8313.4479.3014.0115.4810.07
EV/Sales Ratio
3.844.095.284.773.492.82
EV/EBITDA Ratio
18.8818.4320.1711.8216.8711.42
EV/EBIT Ratio
25.6923.5824.8412.9119.0313.22
EV/FCF Ratio
20.4121.73203.7815.7020.1512.89
Debt / Equity Ratio
1.041.041.270.421.480.70
Debt / EBITDA Ratio
4.224.224.060.863.441.80
Debt / FCF Ratio
5.105.1041.981.164.182.07
Net Debt / Equity Ratio
0.750.750.880.140.790.42
Net Debt / EBITDA Ratio
3.113.112.860.281.881.08
Net Debt / FCF Ratio
3.663.6628.890.372.241.22
Asset Turnover
0.420.420.490.590.700.68
Inventory Turnover
2.512.512.523.485.193.16
Quick Ratio
1.111.111.240.910.950.96
Current Ratio
1.451.451.691.291.171.52
Return on Equity (ROE)
27.46%27.46%31.61%36.34%33.80%26.69%
Return on Assets (ROA)
4.56%4.56%6.56%13.70%7.97%9.10%
Return on Invested Capital (ROIC)
9.05%9.48%14.49%35.16%21.42%16.76%
Return on Capital Employed (ROCE)
10.50%10.50%11.70%31.10%15.70%18.90%
Earnings Yield
5.16%4.93%4.96%4.69%4.47%6.02%
FCF Yield
6.19%5.91%0.58%6.68%5.83%8.62%
Dividend Yield
2.17%2.05%2.27%1.94%2.01%2.01%
Payout Ratio
48.60%48.60%32.00%20.43%17.16%14.64%
Buyback Yield / Dilution
-33.62%-33.62%-13.61%-4.93%-1.41%-0.86%
Total Shareholder Return
-31.42%-31.57%-11.33%-2.99%0.61%1.16%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.